March 2020 | Volume 2
MOVING INTELLIGENT CHANGE FORWARD
INNOVATION DIGEST
Amidst the hailstorm of important information about COVID-19, let’s not forget that there are plenty of pressing issues in healthcare that have a more universal and longer-lasting impact on this nation’s well-being. The relationship between clinician and patient is imperative now more than ever. Issues related to what and how patient-related data are used to make decisions from payment to coverage affect a host of conditions, both episodic and chronic. And we shouldn’t forget other health situations that are frankly at epidemic proportions even before the unseen virus: loneliness, addiction, and suicide to name a few. I have enormous respect for the frontline caregivers and especially the infectious disease expert-heros who are being taxed extra right now. I wish good health to all (now go wash your hands!)
Improving Physician Communication About Treatment Decisions
Patient-physician conversations around prevention and treatment decisions are fundamental to good medical care. Optimal communication is needed for shared decision-making that enables patients to make evidence-informed choices. Clearly, the words physicians use have a critical function in this communication.
doctor_patient.jpg
Hub providers can be the source of the best real-world evidence
Value- or outcomes-based contracting is the buzz of the moment in specialty pharmaceutical marketing. Interest in it is driven by the (typically) high cost of the therapies, and payers’ desire to ensure that they’re getting something for the money expended, In the single-payer systems in Europe, generally speaking, these issues are addressed by health technology assessments; in the US, with its decentralized, pay-as-you-go practices, the value-based contract (VBC) is becoming a viable practice.
pharmacy2.jpg
Battling the Modern Behavioral Epidemic of Loneliness
Since ancient times, millions of people have died of epidemics of plague, flu, cholera, and other infections caused by bacteria, viruses, or other microorganisms. Major advances in medicine have largely eliminated these mass killers with vaccines and antibiotics. However, modern societies are facing a new kind of epidemics: behavioral epidemics. The annual rates of mortality by suicides and opioid overdose have been escalating over the last 2 decades and today are responsible for the death of 1 American every 5.5 minutes.
which_road_business.jpg
It’s Now or Never for National Data Strategies
Everybody seems to agree that data will play a fundamental role in the economy of the future, whether through health discoveries, smart energy grids, autonomous vehicles, or other areas of innovation. The problem is that nobody knows precisely how the new forms of economic value will be created, who will benefit, or what the regulatory response should be.
future_technology.jpg
Are Clinical Trials Doing Enough to Assess Patient Quality of Life?
Quality of life is only measured during the intervention stage of a clinical trial, according to a study published in JAMA Network Open, raising questions about how researchers gather patient-reported outcomes measures during clinical research. In addition to understanding the actual clinical quality improvements a certain care intervention can have, clinical researchers are largely concerned with measures of quality of life throughout the clinical trial process.
doctor_pills2.jpg

Passion + Quality = Change That Matters
  
I embrace the powerful opportunities in our evolving health care landscape. I founded Momentum Health Strategies to be a catalyst for change through continuous learning, diverse engagement and thoughtful policy and practice initiatives. I deliver innovative, strategic thinking and a passion for improving the patient experience. My personal drive and dedication to high-quality results will help you navigate the competitive terrain you face and convert your vision to action.

Momentum Health Strategies

Jennifer L Bright, MPA
(703) 628 - 0534
STAY CONNECTED